![Jasmina Marjanovic](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jasmina Marjanovic
Directeur/Bestuurslid bij New England Venture Capital Association, Inc.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Kevin Bitterman | M | 47 |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | 7 jaar |
Lily Lyman | F | - |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | 2 jaar |
Katie Fanning | F | - |
Mozart Therapeutics, Inc.
![]() Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | - |
Stephen Kraus | M | 47 |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | - |
Neil Exter | M | 65 |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | - |
Liam Donohue | M | - |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | - |
Anna Palmer | F | - |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | 1 jaar |
Marian Nakada | M | - |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | 7 jaar |
Peter Dudek | M | - |
Mozart Therapeutics, Inc.
![]() Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | 4 jaar |
Stefan Vitorovic | M | 39 |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | 1 jaar |
Colleen Cuffaro | M | - |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | - |
Ben Auspitz | M | - |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | - |
Nancy Brown | F | - |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | - |
Margarita I. Chavez | F | - |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | - |
Lucio Iannone | M | 41 |
Mozart Therapeutics, Inc.
![]() Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | 3 jaar |
Julie Gilmore | M | - |
Mozart Therapeutics, Inc.
![]() Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | - |
Jan Beck | M | - |
Mozart Therapeutics, Inc.
![]() Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | 2 jaar |
Marie-Claire Peakman | F | - |
Mozart Therapeutics, Inc.
![]() Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | 1 jaar |
Lisette Tellez | F | - |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | - |
Melissa Gilliam | M | 58 |
The University of Chicago
| 19 jaar |
Joshua Resnick | M | 49 |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | - |
Yumin Choi | M | - |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | 7 jaar |
Darshana Zaveri | F | - |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | 1 jaar |
Steven Gillis | M | 71 |
Mozart Therapeutics, Inc.
![]() Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | - |
Michael Walter Vannier | M | 75 |
The University of Chicago
| 20 jaar |
Jeffrey Bussgang | M | - |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | 7 jaar |
Ellen Rubin | F | 55 |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | - |
Thomas Daniel | M | 70 |
Mozart Therapeutics, Inc.
![]() Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | 4 jaar |
Dayna Grayson | F | 47 |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | - |
Murat Bicer | M | - |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | - |
Ben Bailey | M | 75 |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | - |
Richard Bennett | M | 46 |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | 1 jaar |
Johannes Nielsen | M | - |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | - |
Rudina Seseri | F | 46 |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | 1 jaar |
Sara Nayeem | M | 75 |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | - |
Henrijette Richter | M | 53 |
Mozart Therapeutics, Inc.
![]() Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | - |
K. Christopher Garcia | M | - |
Mozart Therapeutics, Inc.
![]() Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | - |
Ari Glantz | M | - |
New England Venture Capital Association, Inc.
![]() New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Hoossam Malek | M | - |
The University of Chicago
| 3 jaar |
Laszlo Korsos | M | - |
The University of Chicago
| 5 jaar |
Hays Golden | M | 39 |
The University of Chicago
| 11 jaar |
Jason L. Wyman | M | - |
The University of Chicago
| 8 jaar |
Lukasz Pomorski | M | - |
The University of Chicago
| 3 jaar |
Amer Hasan | M | - |
The University of Chicago
| 7 jaar |
Kimerling Daniel | M | - |
The University of Chicago
| 4 jaar |
Feng Li | M | 48 |
The University of Chicago
| 3 jaar |
Taylor Feehley | M | - |
The University of Chicago
| 10 jaar |
Bradley Mills Feingerts | M | - |
The University of Chicago
| 4 jaar |
Ke Cheng | M | - |
The University of Chicago
| 3 jaar |
John Scotti | M | - |
The University of Chicago
| 4 jaar |
Rodney Nelson | M | - |
The University of Chicago
| 4 jaar |
Charles Hachten | M | - |
The University of Chicago
| 9 jaar |
James Crown | M | 70 |
The University of Chicago
| 18 jaar |
Matt Hutchison | M | - |
The University of Chicago
| 3 jaar |
Gerald S. Tannenbaum | M | - |
The University of Chicago
| 7 jaar |
Peishan Tan | M | - |
The University of Chicago
| 5 jaar |
Oleg Gurin | M | - |
The University of Chicago
| 2 jaar |
Jeremy Evan Milim | M | - |
The University of Chicago
| 2 jaar |
Andrew Curran Ross | M | - |
The University of Chicago
| 2 jaar |
Eric Guzman | M | - |
The University of Chicago
| 2 jaar |
Paul Jordan Arnold | M | 41 |
The University of Chicago
| 3 jaar |
Alec Nicholas Lance | M | - |
The University of Chicago
| 4 jaar |
Ali Sheikh | M | - |
The University of Chicago
| 4 jaar |
Deva Meenakshisundaram | M | - |
The University of Chicago
| 4 jaar |
Emily Xia-Reinert | F | - |
The University of Chicago
| 4 jaar |
Travis J. Krueger | M | - |
The University of Chicago
| 3 jaar |
Joshua D. Kramer | M | - |
The University of Chicago
| 2 jaar |
Samuel Everritt Miller | M | - |
The University of Chicago
| 3 jaar |
Ana M. Winters | F | - |
The University of Chicago
| 2 jaar |
Matthew John Adams | M | - |
The University of Chicago
| 2 jaar |
Dan D. Schlemmer | M | - |
The University of Chicago
| 2 jaar |
Marta Melar New | M | 44 |
University of Novi Sad
| 4 jaar |
Jonathan Ho | M | - |
The University of Chicago
| 2 jaar |
Koh Kim | F | - |
The University of Chicago
| 4 jaar |
Hiroyuki Sato | M | - |
The University of Chicago
| 5 jaar |
Jamil Haque Soriano | M | - |
The University of Chicago
| 2 jaar |
Scott Shih Yau Shiao | M | - |
The University of Chicago
| 2 jaar |
Eric Fishel | M | - |
The University of Chicago
| 2 jaar |
Diana S. Rashkow | F | - |
The University of Chicago
| 2 jaar |
Pranay Gupta Laharia | M | - |
The University of Chicago
| 2 jaar |
Alexander Shire | M | - |
The University of Chicago
| 2 jaar |
Ryan Gembala | M | - |
The University of Chicago
| 2 jaar |
Steven Xi | M | - |
The University of Chicago
| 2 jaar |
Shane Kokkines | M | - |
The University of Chicago
| 2 jaar |
Michael P. Jordan | M | - |
The University of Chicago
| 2 jaar |
Justin Lam | M | - |
The University of Chicago
| 4 jaar |
Chris Kocinski | M | - |
The University of Chicago
| 3 jaar |
Reed Singer | M | - |
The University of Chicago
| 2 jaar |
David Fei Fang | M | - |
The University of Chicago
| 4 jaar |
Imran Ahmad | M | - |
The University of Chicago
| 4 jaar |
Scott D. Kauffman | M | - |
The University of Chicago
| 2 jaar |
Mike Gershowitz | M | - |
The University of Chicago
| 2 jaar |
Fred Lee | M | - |
The University of Chicago
| 2 jaar |
Ivana Delevska | F | - |
The University of Chicago
| 4 jaar |
Yana Krivozus | F | - |
The University of Chicago
| 4 jaar |
Steven Richard Ruh | M | - |
The University of Chicago
| 3 jaar |
Alfredo Pinel | M | - |
The University of Chicago
| 2 jaar |
Tyler Brown | M | - |
The University of Chicago
| 4 jaar |
Michael Melby | M | - |
The University of Chicago
| 2 jaar |
Yuujiro Goto | M | - |
The University of Chicago
| 12 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 99 | 99.00% |
Servië | 1 | 1.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Jasmina Marjanovic
- Persoonlijk netwerk